Evidence map›Paper›PMID 40421094›Full record

ArticleFrontiers in oncology2025

Adriana Reyes-León, Eduardo Castro-Vargas, Ma Del Rocío Juárez-Velázquez, Daniel Martínez Anaya, Consuelo Salas-Labadía, Dafné Moreno-Lorenzana, César Alejandro Galván-Díaz, Norma López-Santiago, Eduardo García-Padilla, Alda Daniela García-Guzmán and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adriana Reyes-LeónLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Eduardo Castro-VargasLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Ma Del Rocío Juárez-VelázquezLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Daniel Martínez AnayaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Consuelo Salas-LabadíaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Dafné Moreno-LorenzanaCONAHCYT-Instituto Nacional de Pediatría, Ciudad de México, Mexico.
César Alejandro Galván-DíazServicio de Oncología, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Norma López-SantiagoServicio de Hematología, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Eduardo García-PadillaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Alda Daniela García-GuzmánServicio de Oncología, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Isabel Medina-VeraDepartamento de Metodología de la Investigación, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
Patricia Pérez-VeraLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Ciudad de México, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, we evaluated rs3824662 and rs3781093 as predisposition markers for pre-B ALL in Mexican children using Taqman probes. Results: Both risk alleles were found to be associated with susceptibility to pre-B ALL, predisposition to Discussion: Further studies on the relationship between nutritional status and

Indexed as

childrenCRLF2 overexpressionMexicansobesityoverweightpre-B acute lymphoblastic leukemiaSNPs in GATA3

Identifiers

PMID40421094
PMCPMC12104813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.